In 2022, ECDC and its partners have continued their efforts through the EU Initiative on Health Security to further strengthen the regional workforce for the prevention and control of challenges posed by communicable diseases in the EU enlargement and the EU Neighbourhood Policy Partner (ENP) countries.
This policy elaborates upon how scientific integrity – with a special focus on scientific independence – is to be maintained during all ECDC scientific activity, whether conducted internally or in collaboration with other parties.
Influenza activity had been decreasing across the Region until week 4/2023, following a peak at week 51/2022, but has fluctuated around 25% since week 6/2023 due to increased type B virus circulation.
Resistance of Salmonella and Campylobacter to commonly used antimicrobials is frequently observed in humans and animals, reveals a report by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
This report provides an overview of the main findings of the 2020–2021 harmonised AMR monitoring in Salmonella spp., Campylobacter jejuni and C. coli in humans and food-producing animals and relevant meat thereof.